The initiative, backed by a total financial outlay of Rs 5,000 Crore (nearly $600 million) spanning from FY 2023-24 to FY ...

In this continuation of a three-part series, the author explores the potential use of agentic AI in pharmaceutical R&D.

In the conclusion of this three-part series, the author explores the potential use of agentic AI in pharmaceutical R&D.

"Pharma R&D set to endure despite rising MFN costs" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

The number of “innovation champions” in the pharma industry working on infectious diseases is dropping — and that’s troubling ...

This story was originally published on PharmaVoice. To receive daily news and insights, subscribe to our free daily PharmaVoice newsletter. Deal announcements often showcase where the stars align in ...

India’s ₹5,000-cr plan opens applications to fund pharma and medtech R&D, helping firms move beyond low-cost generics toward ...

The importance of AI in pharma and life sciences cannot be overstated. Regardless of the aspect of industry you examine, you’ll see how AI is reshaping it for the better. Because of this, it’s time ...

Pharmaceutical stocks, particularly Indian firms, plummeted following President Trump's announcement of 100% tariffs on imported branded medicines to ...